𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sclerotherapy in Noncirrhotic Portal Fibrosis

✍ Scribed by Y. K. Chawla; J. B. Dilawari; R. K. Dhiman; M. K. Goenka; D. K. Bhasin; R. Kochhar; K. Singh; U. Kaur

Book ID
110377473
Publisher
Springer US
Year
1997
Tongue
English
Weight
99 KB
Volume
42
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sonographic findings in noncirrhotic por
Sonographic findings in noncirrhotic portal fibrosis
✍ GΓΌrkaynak, GΓΆnΓΌl; Yildirim, BΓΌlent; Aksoy, Fehmi; TemuΓ§in, GΓΌlay πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 386 KB πŸ‘ 2 views

## Purpose: The aim of this study was to evaluate the sonographic appearances of noncirrhotic portal fibrosis (ncpf). ## Methods: Between 1983 and 1996, 12 patients between the ages of 16 and 60 years were diagnosed with ncpf on the basis of medical history and clinical, imaging, and biopsy findi

Noncirrhotic presinusoidal portal hypert
Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis–associated liver disease
✍ Peter Witters; Louis Libbrecht; Tania Roskams; Kris De Boeck; Lieven Dupont; Mar πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.